Repare Therapeutics Inc. (RPTX) Tops Q4 EPS by 14c

Repare Therapeutics Inc. (NASDAQ: RPTX) reported Q4 EPS of ($0.67), $0.14 better than the analyst estimate of ($0.81).

For earnings history and earnings-related data on Repare Therapeutics Inc. (RPTX) click here.

You May Also Be Interested In

• Citi cuts Lowe's price target to $260, keeps Buy rating
• Autodesk (ADSK) PT Raised to $277 at Guggenheim
• Beam Global (BEEM) Tops Q2 EPS by 8c